WebMD to Present at the William Blair 28th Annual Growth Stock ... ( NEW YORK June 16 /- WebMD Health ...)

WebMD to Present at the William Blair 28th Annual Growth Stock Conference

Date:6/16/2008

NEW YORK, June 16 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD) and HLTH Corporation (Nasdaq: HLTH) today announced that executives of WebMD are scheduled to participate at the William Blair 28th Annual Growth Stock Conference on Wednesday, June 18, 2008 at 1:30 p.m. ET.

Investors, analysts and the general public are invited to listen to a live audio broadcast of the presentation over the Internet. The broadcast can be accessed at http://www.wbmd.com (in the Investor Relations section). A replay of the broadcast will be available at the same web address.

About WebMD

WebMD Health Corp. (NASDAQ: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. WebMD Health Corp. is a subsidiary of HLTH Corporation (NASDAQ: HLTH).

All statements contained in this press release, other than statements of historical fact, are forward-looking statements. These statements are based on WebMD's current plans and expectations and involve risks and uncertainties, including those described in our SEC filings.

Contacts:

Investors:
'/>"/>

SOURCE WebMD
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. WebMD Reports Preliminary Third Quarter Financial Results
2. WebMD to Present at Upcoming Investor Conferences
3. HLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference Call
4. WebMD to Present at the Morgan Stanley Technology Conference
5. HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call
6. WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008
7. WebMD to Present at the Third Annual Needham & Company Internet & Digital Media Conference
8. WebMD Announces First Quarter Financial Results
9. WebMD to Present at the Goldman Sachs Ninth Annual Internet Conference
10. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
11. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference

Post Your Comments:

(Date:12/3/2009)...re-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ... Texas skilled nursing facilities: the 93-bed Gran...n McAllen, the 100-bed Alta Vista Rehabilitation &...anda Rehabilitation & Healthcare in Harlingen.... ,, (Logo: http://www.newscom.com/cgi-bin/prn...

(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Sterilization Technologies: The U.S. Market ...lization-Technologies-The-US-Market.html ,, De...t to the sterilization industry in 2008, and forec...2009-2014. ,, Explains how the trends of value-...

(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Antibiotic Resistance and Antibiotic Technolog...r.com/p0166825/Antibiotic-Resistance-and-Antibioti...an in-depth review of the global market for antibi..., Offer an analysis of antibiotics resistance from...

(Date:12/2/2009)...tes of hospital arrival, study finds , ,...e program to get faster treatment for people with ...lly reduced the time between hospital arrival and ...ers of people with STEMI heart attacks -- so calle...ows major blockage of a heart artery -- were recei...

(Date:12/2/2009)...ome, NIH director says, , , WEDNESDAY, ...es have been added to the pool that scientists can...uch lines will soon be made available, U.S. health... first additional embryonic stem cell lines approv...utes of Health (NIH) since President Barack Obama ...

[0] The Ensign Group Acquires Three Texas Skilled Nursing Facilities [0] Reportlinker Adds Sterilization Technologies: The U.S. Market [0] Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets [0] Heart Attack Treatment Speeds Up Nationwide [0] U.S. Approves New Stem Cell Lines for Publicly Funded Research

... can now boast of their first FDA-approved pill ca...sible only due to the creation// of a new molecule...ule, identified by the name TMC-114, and also know...n the departments of chemistry and medicinal chemi...

...tudy has indicated that women with endometrial can...t could mean a risk factor of many other cancers//... or about one in 50, recently diagnosed endometria...C. People with Lynch syndrome mutations are...

...arge supermarkets in UK, namely Tesco, Sainsbury’s... from their products//. The supermarkets hav...l, which is the main source of trans fats from all...disease, and has also been linked to certain forms...

...of doctors, in their article in the British Medica...e possibility of setting off// the alarms in airpo... Radiation treatment is frequently used to treat ...in Florida six weeks after his treatment. It was r...

...Food and Drug Administration has approved a drug c...genital herpes and cold sores. //The drug is manuf...tended to be taken by people with healthy immune s...so, but relieves some of the symptoms. The Cent...

...hers from Glasgow Caledonian University have found...mbling problem. They conducted a survey of more th...and and discovered that almost 9 percent of childr...he children had a problem, researchers said. Scotl...

Other Medicine News:Health News:Finally, The First Ever Treatment for Drug-Resistant HIV 2 Health News:Finally, The First Ever Treatment for Drug-Resistant HIV 3 Health News:Finally, The First Ever Treatment for Drug-Resistant HIV 4 Health News:Uterine cancer may be associated with inherited mutations and a risk of many cancers 2 Health News:Uterine cancer may be associated with inherited mutations and a risk of many cancers 3 Health News:Supermarket Chains In UK To Ban The Use Of Trans Fats 2

Finally, The First Ever Treatment for Drug-Resistant HIV Uterine cancer may be associated with inherited mutations and a risk of many cancers Supermarket Chains In UK To Ban The Use Of Trans Fats Patients Receiving Treatment with Radiotherapy Might trigger Security Alarms FDA Approves Famvir For Genital Herpes Scottish Children Attracted To Serious Gambling

(Date:12/2/2009)... , NEW YORK, Dec. 2 R...ch report is available in its catalogue: ,, Ar...www.reportlinker.com/p0164303/Arthroscopes---A-Wor...procedures are on rise, owing to their mounting sc...kles, elbow, wrists, and hips, apart from knees. T...

(Date:12/2/2009)... , PALO ALTO, Calif., Dec. 2 /PRNewswire-F...ed that on November 25, 2009, Varian, Inc. filed w...s Annual Report on Form 10-K for the fiscal year e...ccessed through the Company,s web site at www.vari...ings," and then on "10-K" in the table shown. Sto...

(Date:12/2/2009)... , NEW YORK, Dec. 2 R...ch report is available in its catalogue: ,, P...et Trends ,, http://www.reportlinker.com/p0...bal-Market-Trends.html ,, Global pharma indu...easing competition in generic markets, rising cost...

Breaking Medicine Technology:Reportlinker Adds Arthroscopes - A World Market Review 2 Reportlinker Adds Arthroscopes - A World Market Review 3 Reportlinker Adds Arthroscopes - A World Market Review 4 Reportlinker Adds Arthroscopes - A World Market Review 5 Reportlinker Adds Arthroscopes - A World Market Review 6 Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2 Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3 Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4 Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5 Association for Molecular Pathology comments to the SACGHS 49088 1 Association for Molecular Pathology comments to the SACGHS 49088 2 Income education important factors in heart disease risk 49084 1 Income education important factors in heart disease risk 49084 2 Safety Kleen Announces 24100 000 Commitment to American Heart Association Start 21 Dallas Heart Walk 49082 1 Safety Kleen Announces 24100 000 Commitment to American Heart Association Start 21 Dallas Heart Walk 49082 2

[0] Reportlinker Adds Arthroscopes - A World Market Review [0] Varian, Inc. Announces Form 10-K Filing [0] Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends

...stracts 186 and 1003, Sanofi-aventis announced to..., presented at the 44th annual meeting of the Euro...demonstrated that a basal-bolus insulin,regimen wi...tion) once,daily (basal insulin) and rapid-acting ...on) at mealtime (bolus insulin) produced greater A...

...nique combination of micronutrients superior to, c... by new omega-3 study -, HOUSTON, Sept. 10 A lan...ers found that TOZAL(R), a patented,combination of... with "dry",macular degeneration to improve their ...eceived the "AREDS-type" nutritional formulation (...

Other Medicine Technology:Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 2 Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 3 Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 4 TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration 2 TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration 3

Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration

Eppendorf sealing mat, 96 well

Chemically Resistant Sealing Mat for 384-well Plate

96-well Silicone Compression

Sealing Mat for 384-well PCR plate

Medicine Products:

Eppendorf sealing mat, 96 well Chemically Resistant Sealing Mat for 384-well Plate 96-well Silicone Compression Sealing Mat for 384-well PCR plate

WebMD to Present at the William Blair 28th Annual Growth Stock ...( NEW YORK June 16 /- WebMD Health ...),Health